Abstract
This commentary highlights the article by Ge et al, which proposes the use of methylation and expression of SRD5A2 as a gene signature to tailor therapies for prostatic diseases.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Comment
MeSH terms
-
3-Oxo-5-alpha-Steroid 4-Dehydrogenase / metabolism*
-
Aging / metabolism*
-
Animals
-
DNA (Cytosine-5-)-Methyltransferases / metabolism*
-
Humans
-
Male
-
Membrane Proteins / metabolism*
-
Prostate / metabolism*
-
Prostatic Hyperplasia / metabolism*
Substances
-
Membrane Proteins
-
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
-
DNA (Cytosine-5-)-Methyltransferases